| Product Code: ETC9945213 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Gene Therapy Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Gene Therapy Market - Industry Life Cycle |
3.4 United Kingdom (UK) Gene Therapy Market - Porter's Five Forces |
3.5 United Kingdom (UK) Gene Therapy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Gene Therapy Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 United Kingdom (UK) Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in the UK |
4.2.2 Growing investments in research and development in gene therapy |
4.2.3 Favorable government initiatives and policies supporting gene therapy advancements |
4.3 Market Restraints |
4.3.1 High costs associated with gene therapy treatments |
4.3.2 Regulatory challenges and approval process for gene therapy products in the UK |
5 United Kingdom (UK) Gene Therapy Market Trends |
6 United Kingdom (UK) Gene Therapy Market, By Types |
6.1 United Kingdom (UK) Gene Therapy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Media, 2021- 2031F |
6.1.5 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Sera, 2021- 2031F |
6.1.6 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 United Kingdom (UK) Gene Therapy Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.2.3 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.2.4 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.2.5 United Kingdom (UK) Gene Therapy Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 United Kingdom (UK) Gene Therapy Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Gene Therapy Market Export to Major Countries |
7.2 United Kingdom (UK) Gene Therapy Market Imports from Major Countries |
8 United Kingdom (UK) Gene Therapy Market Key Performance Indicators |
8.1 Number of clinical trials for gene therapy in the UK |
8.2 Funding and grants allocated to gene therapy research projects |
8.3 Adoption rate of gene therapy treatments in different regions of the UK |
9 United Kingdom (UK) Gene Therapy Market - Opportunity Assessment |
9.1 United Kingdom (UK) Gene Therapy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Gene Therapy Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 United Kingdom (UK) Gene Therapy Market - Competitive Landscape |
10.1 United Kingdom (UK) Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here